A Study of Brivaracetam in Subjects With Partial Onset Seizures
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
This trial will evaluate the efficacy and safety of brivaracetam (at doses of 50 and 150
mg/day in twice a day administration) as add on therapy in subjects with focal epilepsy